EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Local Treatment of Hepatocellular Carcinoma with Oligometastases: A Systematic Review and Meta-Analysis

Sooyeon Kim, Jungsue Lee, Chai Hong Rim iD

Cancers · 02.07.2023 · 15 (13) · 3467

DOI: 10.3390/cancers15133467 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Cancers, online erschienen am 02.07.2023. Verfasst von Sooyeon Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Korea University, Seoul 02841, Republic of Korea. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National research fund of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although recent studies have shown favorable results after local treatment for oligometastases, the clinical decision of applying local treatment for oligometastatic hepatocellular carcinoma (HCC) remains controversial. This meta-analysis aimed to investigate the benefits of local treatment for HCC oligometastases. Pubmed, Embase, Medline, and the Cochrane library were searched for studies until 1 May 2022. Clinical studies involving at least five cases of HCC oligometsatases treated with local modalities were included. The primary endpoint was overall survival (OS). The benefit of local treatment was assessed as the pooled odds ratio (OR) among comparative series, and the pooled OS percentile was calculated from all studies including patients treated with local treatment. Complications of grade ≥ 3 were assessed subjectively. A total of 10 studies involving 527 patients were included. Radiotherapy and radiofrequency ablation (RFA) were mainly performed (six and five studies) as local modalities treating oligometastases. Pooled OR of comparative series favored the use of local treatment (4.664, 95% confidence interval [CI]: 2.595–8.380, p < 0.001, I2: ~0.0%). Including all cohorts with patients who underwent local treatment, pooled rates of 1-year OS were 71.8% (95% CI: 59.0–81.9; I2 = 81.5%), and pooled 2-year OS were 43.3% (95% CI: 29.1–59.6; I2 = 85.4%). Except for temporal or pre-existing toxicities, grade ≤ 3 complications were reported less than 10% in most studies, although common toxicities include pneumothorax and hematologic deficiency after RFA and radiotherapy, respectively. Grade 5 toxicity has not yet been reported. This systematic review supports the application of local treatment for treating HCC oligometastases.

Schlagwörter

Stichwörter der Autor:innen

hepatocellular carcinomaoligometastasesradiofrequency ablationradiotherapy

Autor:innen und Institutionen

  • College of Medicine, Korea University, Seoul 02841, Republic of Korea.
  • Department of Radiation Oncology, Korea University Ansan Hospital, Ansan 15355, Republic of Korea.

ORCID-Profile: Chai Hong Rim

Förderung

  • National research fund of Korea

Zitieren

APA

Kim, S., Lee, J., & Rim, C. H. (2023). Local Treatment of Hepatocellular Carcinoma with Oligometastases: A Systematic Review and Meta-Analysis. Cancers, 15(13), 3467. https://doi.org/10.3390/cancers15133467

Vancouver

Kim S, Lee J, Rim CH. Local Treatment of Hepatocellular Carcinoma with Oligometastases: A Systematic Review and Meta-Analysis. Cancers. 2023;15(13):3467. doi:10.3390/cancers15133467

BibTeX
@article{Kim2023,
  author = {Kim, Sooyeon and Lee, Jungsue and Rim, Chai Hong},
  title = {Local Treatment of Hepatocellular Carcinoma with Oligometastases: A Systematic Review and Meta-Analysis},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {13},
  pages = {3467},
  doi = {10.3390/cancers15133467}
}
Kostenlos starten →